Rare cancers and early drug development
- This topic has 0 replies, 1 voice, and was last updated 8 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
For many years, NCI has partnered with the pharmaceutical industry to develop new cancer therapies. Much of this work has focused on developing therapies that could be used to treat rare cancers, for which there is a great unmet need for effective agents.
http://www.cancer.gov/news-events/cancer-currents-blog/2016/etctn-expanding?cid=eb_govdel
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.